Cornelius J. Clancy
Impact in
- Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance
- Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antifungal resistance and susceptibility 126
- Epidemiology 116
- Fungal Infections and Studies 62
- Pneumocystis jirovecii pneumonia detection and treatment 39
- Pneumonia and Respiratory Infections 16
- Co-authors
- M. Hong Nguyen (102 shared papers)M. Hong Nguyen (98 shared papers)Ryan K. Shields (88 shared papers)Ellen G. Press (27 shared papers)Peter G. Pappas (9 shared papers)Luis Ostrosky‐Zeichner (7 shared papers)José A. Vázquez (6 shared papers)Thomas J. Walsh (4 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (62 papers)Open Forum Infectious Diseases (36 papers)Clinical Infectious Diseases (33 papers)The Journal of Heart and Lung Transplantation (10 papers)Journal of Clinical Microbiology (9 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Cornelius J. Clancy
251 papers receiving 17.1k citations
Cornelius J. Clancy's Hit Papers
Peers
Comparison fields: 5 of 147
- Applied Microbiology and Biotechnology 2.1k
- Molecular Medicine 4.7k
- Infectious Diseases 8.5k
- Epidemiology 6.9k
- Pharmacology 3.1k
Countries citing papers authored by Cornelius J. Clancy
This map shows the geographic impact of Cornelius J. Clancy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelius J. Clancy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelius J. Clancy more than expected).
Fields of papers citing papers by Cornelius J. Clancy
This network shows the impact of papers produced by Cornelius J. Clancy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelius J. Clancy. The network helps show where Cornelius J. Clancy may publish in the future.
Co-authors
The 25 scholars most cited alongside Cornelius J. Clancy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 258 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2015 | 2718 |
| 2 | Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2016 | 985 |
| 3 | Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care Hit paper breakdown → | 2013 | 497 |
| 4 | Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections Hit paper breakdown → | 2023 | 435 |
| 5 | Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections Hit paper breakdown → | 2016 | 400 |
| 6 | Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia Hit paper breakdown → | 2017 | 375 |
| 7 | 2016 | 350 | |
| 8 | Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-ResistantAcinetobacter baumannii, andStenotrophomonas maltophiliaInfections Hit paper breakdown → | 2021 | 349 |
| 9 | Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa) Hit paper breakdown → | 2022 | 337 |
| 10 | 2010 | 335 | |
| 11 | Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa) Hit paper breakdown → | 2020 | 321 |
| 12 | Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), andPseudomonas aeruginosawith Difficult-to-Treat Resistance (DTR-P. aeruginosa) Hit paper breakdown → | 2021 | 311 |
| 13 | T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial Hit paper breakdown → | 2015 | 300 |
| 14 | 2018 | 232 | |
| 15 | 2012 | 215 | |
| 16 | 2017 | 209 | |
| 17 | 2020 | 203 | |
| 18 | 2018 | 186 | |
| 19 | 1998 | 176 | |
| 20 | 2017 | 163 |
About Cornelius J. Clancy
Cornelius J. Clancy is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology, having authored 258 papers that have together received 17.4k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (126 papers), Antibiotic Resistance in Bacteria (64 papers), Fungal Infections and Studies (62 papers), Antibiotics Pharmacokinetics and Efficacy (47 papers), Antibiotic Use and Resistance (40 papers), Pneumocystis jirovecii pneumonia detection and treatment (39 papers), Bacterial Identification and Susceptibility Testing (19 papers) and Pneumonia and Respiratory Infections (16 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (2.1k citations), Molecular Medicine (4.7k citations), Infectious Diseases (8.5k citations), Epidemiology (6.9k citations) and Pharmacology (3.1k citations). Cornelius J. Clancy has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include M. Hong Nguyen, M. Hong Nguyen, Ryan K. Shields, Ellen G. Press, Peter G. Pappas, Luis Ostrosky‐Zeichner, José A. Vázquez, Thomas J. Walsh, Robert A. Bonomo and Annette C. Reboli. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Clinical Infectious Diseases, The Journal of Heart and Lung Transplantation and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.